Sign in

CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
870419387
Phone
310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Open-market buy Chairman and CEO bought 1,000 shares at $1.64 ($1,640)
  2. 4 Open-market buy Chairman and CEO bought 2,500 shares at an average $1.69 ($4,235)
  3. 4 Open-market buy Chairman and CEO bought 3,582 shares at an average $1.68 ($6,017)
  4. 4 Open-market buy Vice Chairman & COO bought 3,500 shares at an average $1.60 ($5,585)
  5. 4 Open-market buy Chairman and CEO bought 2,000 shares at $1.50 ($3,000)
  6. 4 Open-market buy Chairman and CEO bought 2,500 shares at $1.67 ($4,175)
  7. 4 Open-market buy Vice Chairman & COO bought 4,000 shares at an average $1.71 ($6,840)
  8. 4 Open-market buy Chairman and CEO bought 3,000 shares at an average $1.67 ($4,995)
  9. 4 Open-market buy Chairman and CEO bought 9,701 shares at an average $1.55 ($15,022)
  10. 10-Q Report Quarterly Report
  11. 10-Q Report Quarterly Report
  12. 4 Open-market buy Vice Chairman & COO bought 4,900 shares at an average $1.56 ($7,624)
  13. 4 Open-market buy Chairman and CEO bought 13,200 shares at an average $1.54 ($20,312)
  14. 10-Q Report Quarterly Report
  15. 10-Q Report Quarterly Report
  16. 10-Q Report Quarterly Report
  17. 4 Open-market buy Chairman and CEO bought 9,200 shares at an average $1.45 ($13,346)
  18. 4 Open-market buy Chairman and CEO bought 4,700 shares at an average $1.50 ($7,043)
  19. 4 Open-market buy Chairman and CEO bought 7,593 shares at an average $1.53 ($11,595)
  20. 4 Open-market buy Chairman and CEO bought 5,100 shares at an average $1.52 ($7,767)

Page 9 of 63 · 1,250 filings